Skip to main content
. 2021 Apr 19;22(8):4242. doi: 10.3390/ijms22084242

Table 1.

Small-molecule inhibitors of influenza A.

Molecules Targeting Model Studied Effects Ref.
EGCG NS1 MDCK cells Decreased the viral NS1 level and viral replication [71]
Quinoxaline NS1 MDCK cells Inhibiting viral replication [72]
JJ3297 NS1 MEF cells Reduced virus replication and produce level of IFN [74]
A22 NS1 NMR Interrupt the NS1-CPSF30 binding [75]
Compound 32056, 31674 NS1 MM-PBSA Binding with NS1 near the W187 [76]
NSC 109834, 128164, 95676, 125044 NS1 MDCK cells Reduced viral M2 protein and RNAs [77]
pyrazolopyridine NS1 MDCK cells Inhibition of virus replication [78]
Compound 3 NS1 MDCK cells Decreased viral protein and replication [79,80]
Baicalin NS1 A549 cells Reduced virus replication and viral NP transcription [81]
RNA oligonucleotide NS1 chicken embryo fibroblast cells Interference to the viral transcription and replication [82]
AG879, tyrphostin A9 Receptor tyrosine kinases A549 cells Inhibit the Crm1 nuclear export pathway and viral RNA synthesis [83]
Quinoline acid dihydroorotate dehydrogenase MDCK cells Inhibition of production pyrimidines that limits virus replication [84]

EGCG: Epigallocatechin gallate; NS1: Non-structural protein 1; MDCK: Madin-Darby Canine Kidney; IFN: Interferon; MEF: Mouse embryonic fibroblast; MM-PBSA: Molecular mechanics Poisson-Boltzmann surface area.